Today's Information

Provided by: AmCad BioMed Corporation
SEQ_NO 5 Date of announcement 2022/02/18 Time of announcement 15:56:47
Subject 
 AmCad BOD revoked non-compete prohibition on
financial and accounting officer
Date of events 2022/02/18 To which item it meets paragraph 21
Statement 
1.Date of the board of directors resolution:2022/02/18
2.Name and title of the managerial officer with
permission to engage in competitive conduct:
 Maureen Chang / financial and accounting officer
3.Items of competitive conduct in which the officer is
permitted to engage:
 as financial and accounting officer in Broadsound Corporation
4.Period of permission to engage in the competitive
conduct:
 During the period as the financial and accounting officer in AmCad
5.Circumstances of the resolution (please describe the
results of voting in accordance with Article 32 of the
Company Act):
 Approved by all the attended directors
6.If the permitted competitive conduct belongs to the
operator of a mainland China enterprise, the name and
 title of the managerial officer (if it is not the
operator of a mainland China enterprise, please enter
"N/A" below):N/A
7.Company name of the mainland China enterprise and the
officer's position in the enterprise:N/A
8.Address of the mainland China enterprise:N/A
9.Operations of the mainland China enterprise:N/A
10.Impact on the company's finance and business:N/A
11.If the managerial officer or director has invested in
 the mainland China enterprise, the monetary amount of the
 investment and the officer or director's shareholding ratio:N/A
12.Any other matters that need to be specified:None

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

AmCad BioMed Corporation published this content on 18 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 February 2022 08:10:01 UTC.